Probably, the first study showing clearly significant heterogeneity in the efficacy of these inhibitors by gender of the patient is of Conforti et al.
← all excerpts
Sex Differences and Adverse Effects between Chemotherapy and Immunotherapy for Non-Small Cell Lung Cancer.
1
—
—